To Evaluate The Combined Effect of Kaishore Guggul and Metformin on Blood Sugar levels and average 3 months blood sugar Levels in Patients with diabetes mellitus

A clinical study to evaluate the effect of Kaishore Guggul with Metformin in Sampraptibhanga of Prameha (Diabetis Mellitus) with special reference to Blood Sugar Level and Glycosylated Hemoglobin (HbA1C) - Kaishore guggul

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106510

Enrollment

Registered

2026-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diabetic Patient having their Fasting blood glucose level more than 80 mg/dl and less than 180 mg/dl. 2.Diabetic Patient having Post prandial blood glucose level more than 200 mg/dl and less than 300 mg/dl. 3.Diabetic Patient having HbA1C more than 6.5 % and less than 10.5 %. 4.Patient who is taking only Metformin regularly.

Exclusion criteria

Exclusion criteria: 1. Patients having age below 30 years and more than 60 years. 2. Patients having Type 1 diabetes mellitus 3. Acromegaly, Cushing s syndrome and Pancreatitis. 4. Pregnant and lactating women. 5. Patient with gestational diabetes. 6. Patient suffering from Hepatic dysfunction, Renal dysfunction or Liver cirrhosis. 7. Those who are under Insulin therapy [IDDM]. 8. Patient with Lactic acidosis, Sepsis. 9. Patients with acute complications like hyperglycemic coma, ketoacidosis and infections like gangrene. 10. Patients with K/C/O Nephropathy, Neuropathy and Retinopathy, gastrointestinal diseases, Tumors, conditions like cardiovascular disease, acute MI, Immune compromised disease [HIV].

Design outcomes

Primary

Measure	Time frame
To Study add on Effect of Kishore Guggul with Metforrmin in management of Prameha ( Diabetis Mellitus Type 2) with specal reference to BSL and HBA1CTimepoint: Patients will be assessed on 30th,60th,90th day of follow up	—

Secondary

Measure	Time frame
1.To study the Nidanapanchaka of Prameha according to Ayurveda Samhita. 2.To study Diabetes mellitus according to modern science. 3.To study Kaishore Guggul in detail. 4.To study the Blood sugar level. 5.To Study the Glycosylated hemoglobin percentage. 6.To compare the add on effect of Kaishore guggul with metformin and only metformin in Prameha (Diabetes mellitus) with special reference to Blood sugar level and Glycosylated hemoglobinTimepoint: Patients will be assessed on 30th,60th,90th day of follow up	—

Measure

Time frame

1.To study the Nidanapanchaka of Prameha according to Ayurveda Samhita. 2.To study Diabetes mellitus according to modern science. 3.To study Kaishore Guggul in detail. 4.To study the Blood sugar level. 5.To Study the Glycosylated hemoglobin percentage. 6.To compare the add on effect of Kaishore guggul with metformin and only metformin in Prameha (Diabetes mellitus) with special reference to Blood sugar level and Glycosylated hemoglobinTimepoint: Patients will be assessed on 30th,60th,90th day of follow up

—

Countries

India

Contacts

Public ContactDrNilam chavan

LRP Ayurvedic medical college and hospital

chavannilam695@gmail.com8208575565

Outcome results